AbbVie 2014 Annual Report Download - page 98

Download and view the complete annual report

Please find page 98 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 182

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182

13NOV201221352027
The table below presents the significant amounts reclassified out of each component of accumulated
other comprehensive loss for the years ended December 31, 2014 and 2013:
years ended December 31 (in millions) 2014 2013
Pension and post-employee benefits
Amortization of actuarial losses and other $ 66 $114
Less tax expense (20) (35)
Total reclassification, net of tax $ 46 $ 79
Hedging activities
Gains (losses) on designated cash flow hedges $(79) $
Less tax expense 2—
Total reclassification, net of tax $(77) $
Other
In addition to common stock, AbbVie’s authorized capital includes 200 million shares of preferred
stock, par value $0.01. As of December 31, 2014, no shares of preferred stock were issued or outstanding.
Note 13 Income Taxes
.....................................................................................................................................................................................................................................................................................................................................................
Earnings Before Income Taxes
years ended December 31 (in millions) 2014 2013 2012
Domestic $(3,245) $ (581) $ 625
Foreign 5,614 5,913 5,100
Total earnings before income taxes $ 2,369 $5,332 $5,725
The increase in the domestic loss before income taxes for the year ended December 31, 2014 was
driven by transaction and financing-related costs associated with the terminated proposed combination with
Shire. Refer to Note 4 for further information.
Income Taxes
years ended December 31 (in millions) 2014 2013 2012
Current
Domestic $ 634 $ 226 $ 94
Foreign 341 354 252
Total current taxes $ 975 $ 580 $346
Deferred
Domestic $(301) $ 678 $ 89
Foreign (79) (54) 15
Total deferred taxes (380) 624 104
Total income taxes $ 595 $1,204 $450
92 2014 Form 10-K